This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2024
Title: Innovations of Zhenhua Wang in Polycyclic Compounds
Introduction
Zhenhua Wang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with potential applications in medicine. His work focuses on the synthesis and application of polycyclic compounds, which are of great interest in pharmaceutical research.
Latest Patents
Wang holds a patent for a unique invention titled "1,4-sulfur-bridged polycyclic compounds containing dihydrobenzofuran structure, its preparation method and application thereof." This invention discloses a 1,4-sulfur-bridged polycyclic compound that features a dihydrobenzofuran structure. The preparation method involves dissolving 2-nitrobenzofuran and 5H-thiazolone in an organic solvent, followed by the addition of a molecular sieve and chiral catalyst. The reaction is conducted under argon protection at room temperature until completion, after which separation and purification yield the desired compound. This innovative method is characterized by its novelty, simplicity, mild reaction conditions, high yield, and high stereoselectivity.
Career Highlights
Throughout his career, Zhenhua Wang has focused on the synthesis of compounds that have significant potential in antitumor drug research. His work has garnered attention for its practical applications and the advantages it offers in drug development.
Collaborations
Wang has collaborated with notable colleagues, including Shun Sheng Zhou and Weicheng Yuan, to further advance his research and innovations in the field.
Conclusion
Zhenhua Wang's contributions to the development of 1,4-sulfur-bridged polycyclic compounds highlight his innovative approach to chemistry and its applications in medicine. His work continues to pave the way for advancements in antitumor drug research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile